Semaglutide 910463-68-2

Somaglutide, English name "Semeglutide", is a new, long-acting, weekly subcutaneous injection of GLP-1 analog. It is a long-acting dosage form developed based on the basic structure of Lilalutide, and has better effect in the treatment of type 2 diabetes.